A Novel Histone Deacetylase Inhibitor, Scriptaid, Enhances Expression of Functional Estrogen Receptor α (ER) in ER negative human breast cancer cells in combination with 5-aza 2′-deoxycytidine

By Keen J.C.   Yan L.   Mack K.M.   Pettit C.   Smith D.   Sharma D.   Davidson N.E.  

Breast Cancer Research and Treatment, Vol. 81, Iss. 3, 2003-10 ,pp. : 177-186

Springer Publishing Company

Access to resources Recommend Favorite

The histone deacetylase inhibitor trichostatin A alters microRNA expression profiles in apoptosis-resistant breast cancer cells

By                      

Oncology Reports, Vol. 27, Iss. 1, 2012-01 ,pp. : 10-16

Spandidos Publications

Access to resources Recommend Favorite

Alteration in protein expression in estrogen receptor alpha-negative human breast cancer tissues indicates a malignant and metastatic phenotype

By Sahab Ziad   Man Yan-Gao   Semaan Suzan   Newcomer Robert   Byers Stephen   Sang Qing-Xiang  

Clinical and Experimental Metastasis, Vol. 27, Iss. 7, 2010-10 ,pp. : 493-503

Springer Publishing Company

Access to resources Recommend Favorite

The histone deacetylase inhibitor trichostatin A induces cell cycle arrest and apoptosis in colorectal cancer cells via p53-dependent and -independent pathways

By Meng Jin   Zhang Hai-Hua   Zhou Chun-Xiang   Li Chen   Zhang Feng   Mei Qi-Bing  

Oncology Reports, Vol. 28, Iss. 1, 2012-07 ,pp. : 384-388

Spandidos Publications

Access to resources Recommend Favorite

Sorafenib and nilotinib resensitize tamoxifen resistant breast cancer cells to tamoxifen treatment via estrogen receptor α

By        

International Journal of Oncology, Vol. 45, Iss. 5, 2014-01 ,pp. : 2167-2175

Spandidos Publications

Access to resources Recommend Favorite